Insiders say move is part of wider internal review, not country-specific, as evidenced by UAE’s decision to quit Opec bloc.
Corvus Pharmaceuticals' lead candidate, Soquelitinib, is advancing towards a Phase 3 trial for PTCL, set to begin in September 2024. Soquelitinib has shown a 26% Complete Response Rate [CRR] in early ...
PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous ...
The Nation (PK) on MSN
PTCL Group back into profits with Rs3.1b bottom-line in Q1
Pakistan Telecommunication Company Limited (PTCL), the country's leading telecom and ICT services provider, has announced its consolidated financial results for the quarter ended March 31, 2026. PTCL ...
In Asia, PTCL diagnosis and management are hindered by the lack of available domain experts, limitations in infrastructure support and funding, and substantial challenges in accessing novel drugs; ...
Peripheral T-cell lymphomas (PTCL) are rare cancers, which stand for about 10% of all non-Hodgkin's lymphomas (NHL) (Harris et al., 1994; The.Non-Hodgkin's.Lymphoma.Classification.Project, 1997). They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results